175 related articles for article (PubMed ID: 20483992)
21. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
22. Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine Strategy.
Wang Q; Bi W; Zhu X; Li H; Qi Q; Yu F; Lu L; Jiang S
J Virol; 2015 Jul; 89(13):6960-4. PubMed ID: 25903343
[TBL] [Abstract][Full Text] [Related]
23. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
[TBL] [Abstract][Full Text] [Related]
25. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
Banerjee S; Shi H; Habte HH; Qin Y; Cho MW
Virology; 2016 Mar; 490():17-26. PubMed ID: 26803471
[TBL] [Abstract][Full Text] [Related]
26. Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion.
Louis JM; Nesheiwat I; Chang L; Clore GM; Bewley CA
J Biol Chem; 2003 May; 278(22):20278-85. PubMed ID: 12654905
[TBL] [Abstract][Full Text] [Related]
27. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
29. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.
Grundner C; Li Y; Louder M; Mascola J; Yang X; Sodroski J; Wyatt R
Virology; 2005 Jan; 331(1):33-46. PubMed ID: 15582651
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ
Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828
[TBL] [Abstract][Full Text] [Related]
33. Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads.
Caulfield MJ; Dudkin VY; Ottinger EA; Getty KL; Zuck PD; Kaufhold RM; Hepler RW; McGaughey GB; Citron M; Hrin RC; Wang YJ; Miller MD; Joyce JG
J Biol Chem; 2010 Dec; 285(52):40604-11. PubMed ID: 20943652
[TBL] [Abstract][Full Text] [Related]
34. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
35. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
[TBL] [Abstract][Full Text] [Related]
36. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
[TBL] [Abstract][Full Text] [Related]
37. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
38. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
39. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies.
Frey G; Chen J; Rits-Volloch S; Freeman MM; Zolla-Pazner S; Chen B
Nat Struct Mol Biol; 2010 Dec; 17(12):1486-91. PubMed ID: 21076402
[TBL] [Abstract][Full Text] [Related]
40. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
Broliden PA; von Gegerfelt A; Clapham P; Rosen J; Fenyö EM; Wahren B; Broliden K
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):461-5. PubMed ID: 1370580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
